Therapeutic Intensification Plus Immunomodulation to Decrease the HIV-1 Viral Reservoir

NCT00976404 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

28

Enrollment

OTHER

Sponsor class

Conditions

HIV Infection

Interventions

BIOLOGICAL: DNA + HIV-rAd5 vaccine
DRUG: ART intensification (raltegravir)
DRUG: ART intensification (maraviroc)

Sponsor

Robert L. Murphy

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]